Jianmin Pharmaceutical Group Co Ltd Free Cash Flow Generation Index
Jianmin Pharmaceutical Group Co Ltd free cash flow generation index. Jianmin Pharmaceutical Group Co Ltd (600976) has a Free Cash Flow Generation Index of 0.78x as of December 2025. Free cash flow of CN¥83.59 Million represents 1% of operating cash flow (CN¥106.82 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Free cash flow generation index of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. Historical FCF Generation Index trend for Jianmin Pharmaceutical Group Co Ltd across 20 annual periods. See Jianmin Pharmaceutical Group Co Ltd (600976) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Jianmin Pharmaceutical Group Co Ltd Free Cash Flow Generation Index by Year (2003–2025)
Jianmin Pharmaceutical Group Co Ltd free cash flow generation index by year from 2003 to 2025. Year-by-year Free Cash Flow Generation Index for Jianmin Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 600976 cash generation efficiency.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥173.86 Million | CN¥274.53 Million | CN¥100.67 Million | ▲ +30.2% |
| 2024 | 0.49x | CN¥113.98 Million | CN¥234.27 Million | CN¥120.29 Million | ▼ -36.0% |
| 2023 | 0.76x | CN¥203.89 Million | CN¥268.39 Million | CN¥64.50 Million | ▲ +10.9% |
| 2022 | 0.69x | CN¥147.90 Million | CN¥215.87 Million | CN¥67.96 Million | ▼ -12.6% |
| 2021 | 0.78x | CN¥203.19 Million | CN¥259.18 Million | CN¥55.99 Million | ▲ +23.1% |
| 2020 | 0.64x | CN¥79.96 Million | CN¥125.54 Million | CN¥45.58 Million | ▲ +823.4% |
| 2019 | 0.07x | CN¥5.13 Million | CN¥74.45 Million | CN¥69.31 Million | ▼ -79.3% |
| 2018 | 0.33x | CN¥21.23 Million | CN¥63.60 Million | CN¥42.37 Million | ▲ +274.4% |
| 2017 | -0.19x | CN¥-6.74 Million | CN¥35.20 Million | CN¥41.93 Million | ▼ -125.8% |
| 2016 | 0.74x | CN¥84.42 Million | CN¥113.84 Million | CN¥29.42 Million | ▲ +92.2% |
| 2015 | 0.39x | CN¥18.70 Million | CN¥48.45 Million | CN¥29.75 Million | ▼ -47.9% |
| 2014 | 0.74x | CN¥76.46 Million | CN¥103.23 Million | CN¥26.77 Million | ▲ +56.6% |
| 2013 | 0.47x | CN¥21.46 Million | CN¥45.36 Million | CN¥23.90 Million | ▼ -47.9% |
| 2012 | 0.91x | CN¥89.21 Million | CN¥98.17 Million | CN¥8.97 Million | ▼ -5.7% |
| 2010 | 0.96x | CN¥144.67 Million | CN¥150.08 Million | CN¥5.41 Million | ▲ +23.2% |
| 2009 | 0.78x | CN¥52.20 Million | CN¥66.69 Million | CN¥14.50 Million | ▼ -15.0% |
| 2008 | 0.92x | CN¥101.42 Million | CN¥110.11 Million | CN¥8.69 Million | ▲ +30.8% |
| 2006 | 0.70x | CN¥39.56 Million | CN¥56.18 Million | CN¥16.61 Million | ▲ +105.4% |
| 2004 | -12.95x | CN¥-53.51 Million | CN¥4.13 Million | CN¥57.64 Million | ▲ +42.1% |
| 2003 | -22.37x | CN¥-93.70 Million | CN¥4.19 Million | CN¥97.88 Million | — |